BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23320811)

  • 1. Crystallization and dissolution behavior of naproxen/polyethylene glycol solid dispersions.
    Zhu Q; Toth SJ; Simpson GJ; Hsu HY; Taylor LS; Harris MT
    J Phys Chem B; 2013 Feb; 117(5):1494-500. PubMed ID: 23320811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of PEG 4000 on the dissolution rate of naproxen.
    Vélaz I; Sánchez M; Martín C; Martínez-Ohárriz MC
    Eur J Drug Metab Pharmacokinet; 1998; 23(2):103-8. PubMed ID: 9725465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermal behavior and dissolution properties of naproxen from binary and ternary solid dispersions.
    Mura P; Faucci MT; Manderioli A; Bramanti G; Parrini P
    Drug Dev Ind Pharm; 1999 Mar; 25(3):257-64. PubMed ID: 10071817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of increased dissolution of diazepam and temazepam from polyethylene glycol 6000 solid dispersions.
    Verheyen S; Blaton N; Kinget R; Van den Mooter G
    Int J Pharm; 2002 Dec; 249(1-2):45-58. PubMed ID: 12433433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studying of crystal growth and overall crystallization of naproxen from binary mixtures.
    Kaminska E; Madejczyk O; Tarnacka M; Jurkiewicz K; Kaminski K; Paluch M
    Eur J Pharm Biopharm; 2017 Apr; 113():75-87. PubMed ID: 28034808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of crystallization behavior in drug/polyethylene glycol solid dispersions.
    Zhu Q; Harris MT; Taylor LS
    Mol Pharm; 2012 Mar; 9(3):546-53. PubMed ID: 22299821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions.
    Patil MP; Gaikwad NJ
    Acta Pharm; 2009 Mar; 59(1):57-65. PubMed ID: 19304558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the microstructure of semicrystalline solid dispersions.
    Zhu Q; Taylor LS; Harris MT
    Mol Pharm; 2010 Aug; 7(4):1291-300. PubMed ID: 20550195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of naproxen with noncrystalline acetyl beta- and acetyl gamma-cyclodextrins in the solid and liquid state.
    Bettinetti G; Mura P; Faucci MT; Sorrenti M; Setti M
    Eur J Pharm Sci; 2002 Feb; 15(1):21-9. PubMed ID: 11803128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystallization Kinetics of Indomethacin/Polyethylene Glycol Dispersions Containing High Drug Loadings.
    Duong TV; Van Humbeeck J; Van den Mooter G
    Mol Pharm; 2015 Jul; 12(7):2493-504. PubMed ID: 26056715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time-resolved SAXS/WAXS study of the phase behavior and microstructural evolution of drug/PEG solid dispersions.
    Zhu Q; Harris MT; Taylor LS
    Mol Pharm; 2011 Jun; 8(3):932-9. PubMed ID: 21452866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting the formation of eutectic solid dispersions and their dissolution behavior.
    Vippagunta SR; Wang Z; Hornung S; Krill SL
    J Pharm Sci; 2007 Feb; 96(2):294-304. PubMed ID: 17051588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneously Improving Mechanical, Formulation, and In Vivo Performance of Naproxen by Co-Crystallization.
    Abbas N; Latif S; Afzal H; Arshad MS; Hussain A; Sadeeqa S; Bukhari NI
    AAPS PharmSciTech; 2018 Oct; 19(7):3249-3257. PubMed ID: 30194682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of rofecoxib-polyethylene glycol 4000 solid dispersions and tablets based on solid dispersions.
    Liu C; Desai KG
    Pharm Dev Technol; 2005; 10(4):467-77. PubMed ID: 16370176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of excipients on solubility and dissolution of pharmaceuticals.
    Paus R; Prudic A; Ji Y
    Int J Pharm; 2015 May; 485(1-2):277-87. PubMed ID: 25749073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and solubility study of norfloxacin-polyethylene glycol, polyvinylpyrrolidone and carbopol 974p solid dispersions.
    Gorajana A; Kit WW; Dua K
    Recent Pat Drug Deliv Formul; 2015; 9(2):167-82. PubMed ID: 25714525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physicochemical characterisation, drug polymer dissolution and in vitro evaluation of phenacetin and phenylbutazone solid dispersions with polyethylene glycol 8000.
    Khan S; Batchelor H; Hanson P; Perrie Y; Mohammed AR
    J Pharm Sci; 2011 Oct; 100(10):4281-94. PubMed ID: 21560130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of the dissolution rate of silymarin by means of solid dispersions.
    Li FQ; Hu JH
    Chem Pharm Bull (Tokyo); 2004 Aug; 52(8):972-3. PubMed ID: 15304992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of prednisone:polyethylene glycol 6000 fast-release tablets from solid dispersions: solid-state characterization, dissolution behavior, and formulation parameters.
    Leonardi D; Barrera MG; Lamas MC; Salomón CJ
    AAPS PharmSciTech; 2007 Dec; 8(4):E108. PubMed ID: 18181529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicochemical characterization and dissolution study of solid dispersions of Lovastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30.
    Patel RP; Patel MM
    Pharm Dev Technol; 2007; 12(1):21-33. PubMed ID: 17484141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.